XML 73 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Divestitures and Sale of License Rights (Narrative) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 02, 2018
Dec. 31, 2016
Sep. 30, 2016
Aug. 31, 2016
Dec. 31, 2014
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Jul. 07, 2016
Divestitures and Sale of License Rights (Details)                                  
(Gain) loss on divestitures           $ 0 $ 0 $ (1,284) $ 0         $ (1,284) $ 0 $ 51,820  
Total revenues           $ 241,026 $ 241,414 $ 239,357 $ 253,980 $ 255,965 $ 270,615 $ 258,026 $ 256,573 975,777 1,041,179 882,060  
Comet Brand                                  
Divestitures and Sale of License Rights (Details)                                  
Proceeds from early buyout         $ 10,000                        
Proceeds from sale of license rights       $ 11,000                          
Gain on sale of asset       1,200                          
Indefinite-lived intangibles, reductions       $ 9,000                          
North American OTC Healthcare                                  
Divestitures and Sale of License Rights (Details)                                  
Total revenues                           $ 862,446 $ 868,874 720,824  
Disposal group, disposed of by sale, not discontinued operations | Household Cleaning                                  
Divestitures and Sale of License Rights (Details)                                  
Total purchase price received $ 65,912                                
Pre-tax gain on divestiture $ 1,284                                
Disposal group, disposed of by sale, not discontinued operations | Pediacare, New Skin and Fiber Choice | Cough and Cold, Dermatologicals, and Gastrointestinal products group | North American OTC Healthcare                                  
Divestitures and Sale of License Rights (Details)                                  
Consideration, excluding costs of inventory                                 $ 40,000
(Gain) loss on divestitures                               $ 56,200  
Disposal group, disposed of by sale, not discontinued operations | Dermoplast | Cough and Cold, Dermatologicals, and Gastrointestinal products group | North American OTC Healthcare                                  
Divestitures and Sale of License Rights (Details)                                  
Deposit for agreement to purchase     $ 1,250                            
Disposal group, disposed of by sale, not discontinued operations | E.P.T. and Dermoplast | Cough and Cold, Dermatologicals, and Gastrointestinal products group | North American OTC Healthcare                                  
Divestitures and Sale of License Rights (Details)                                  
Total purchase price received   $ 59,600                              
Pre-tax net gain on divestitures   $ 3,900                              
Royalty | Comet Brand                                  
Divestitures and Sale of License Rights (Details)                                  
Total revenues         $ 1,000